| 2011 |
ZNRF1, an E3 ubiquitin ligase, promotes Wallerian degeneration by targeting AKT for degradation via the ubiquitin-proteasome system. AKT degradation releases its inhibitory phosphorylation of GSK3B, allowing active GSK3B to phosphorylate CRMP2, which is required for microtubule reorganization in degenerating axons. |
Overexpression and knockdown experiments in neurons, AKT overexpression rescue assay, active GSK3B overexpression, CRMP2 phosphorylation assays, pharmacological GSK3B inhibition |
Nature cell biology |
High |
22057101
|
| 2015 |
Oxidative stress activates ZNRF1 E3 ligase activity through EGFR-mediated phosphorylation at tyrosine 103. NADPH oxidase activity is required for EGFR-dependent phosphorylation of ZNRF1, which then drives AKT degradation via the ubiquitin-proteasome system, leading to neuronal apoptosis and Wallerian degeneration. |
Phosphorylation site mutagenesis (Y103), EGFR inhibition, NADPH oxidase inhibition, ubiquitin-proteasome assays, neuronal degeneration readouts |
The Journal of cell biology |
High |
26572622
|
| 2017 |
ZNRF1 physically interacts with caveolin-1 (CAV1) in response to LPS and mediates K-linked ubiquitination and proteasomal degradation of CAV1. This ZNRF1-CAV1 axis regulates AKT-GSK3β activity downstream of TLR4 activation to enhance pro-inflammatory cytokine production and inhibit IL-10. |
Co-immunoprecipitation, ubiquitination assays, ZNRF1 knockout mice (hematopoietic deletion), cytokine measurements, endotoxic shock model |
Nature communications |
High |
28593998
|
| 2012 |
ZNRF1 and ZNRF2 are N-myristoylated, localizing them to intracellular membranes where they interact with the Na+/K+ATPase α1 subunit via their UBZ domains. Their RING domains interact with E2 Ubc13/Uev1a to mediate Lys63-linked ubiquitination of the cytoplasmic loop of Na+/K+ATPase α1. Ouabain decreases ZNRF1 protein levels; ZNRF2 knockdown inhibits ouabain-induced decrease of Na+/K+ATPase surface levels. |
N-myristoylation assays, Co-immunoprecipitation (UBZ-Na+/K+ATPase interaction), in vitro ubiquitination assays with Lys63-linkage analysis, ZNRF2 knockdown, cell surface biotinylation |
Journal of cell science |
High |
22797923
|
| 2018 |
The crystal structure of ZNRF1 C-terminal domain in complex with Ube2N reveals an unusually high-affinity interaction (Kd ~50 nM) between the ZNRF1 RING domain and Ube2N, compared to ~1 µM for Ube2D2. Mutational analyses confirmed the molecular basis of this affinity. Excess ZNRF1 (≥500 nM) inhibits Ube2N-mediated ubiquitination, suggesting a concentration-dependent autoregulatory mechanism. |
Crystal structure determination, isothermal titration calorimetry (Kd measurement), site-directed mutagenesis, in vitro ubiquitination assays |
The Biochemical journal |
High |
29626159
|
| 2021 |
ZNRF1 mediates ligand-induced EGFR ubiquitination at distinct lysine residues from those targeted by CBL. ZNRF1 deletion inhibits endosome-to-lysosome sorting of EGFR, resulting in delayed receptor degradation and prolonged downstream signaling. Loss of ZNRF1 increases susceptibility to HSV-1 infection due to enhanced EGFR-dependent viral entry. |
ZNRF1 knockout cells, EGFR ubiquitination assays, endosomal trafficking assays, receptor degradation kinetics, lysine-site mapping comparing ZNRF1 vs. CBL, HSV-1 infection assay |
Frontiers in cell and developmental biology |
High |
33996800
|
| 2009 |
ZNRF1 interacts with beta-tubulin type 2 (Tubb2) identified by yeast two-hybrid screening and confirmed by in vivo co-immunoprecipitation. ZNRF1 colocalizes with Tubb2, and both the RING finger domain and zinc finger domain are required for ZNRF1-induced morphological changes (neurite-like elongation). |
Yeast two-hybrid screening, in vivo co-immunoprecipitation, immunofluorescence colocalization, domain deletion analysis |
Biochemical and biophysical research communications |
Medium |
19737534
|
| 2023 |
c-Src kinase, activated by TLR3 engagement, phosphorylates ZNRF1 at tyrosine 103, enabling ZNRF1 to mediate K63-linked ubiquitination of TLR3 at lysine 813, which promotes TLR3 sorting into multivesicular bodies/lysosomes and its degradation, terminating type I interferon signaling. |
ZNRF1 knockout mice and cells, phosphorylation site mapping (Y103), ubiquitination site mapping (K813 of TLR3), TLR3 lysosomal trafficking assays, SARS-CoV-2 and EMCV infection models |
The Journal of experimental medicine |
High |
37158982
|
| 2024 |
In Drosophila, the ZNRF1/2 homologue detour interacts with HOPS complex subunits (VPS18/dor, VPS16A, VPS41/lt) and promotes their ubiquitination, regulating autophagosome-lysosome fusion. In mammalian cells, ablation of ZNRF1 or ZNRF2 increased basal autophagy; overexpression increased autophagic vesicle size. |
Drosophila genetic model (detour depletion/overexpression), mass spectrometry interactome, ubiquitination assays of HOPS subunits, mammalian ZNRF1/2 knockdown with autophagy flux assays |
Communications biology |
Medium |
38360932
|
| 2023 |
LZTFL1 tumor suppressor inhibits kidney tumor cell proliferation by destabilizing AKT through a ZNRF1-mediated ubiquitin-proteasome pathway, placing LZTFL1 upstream of ZNRF1 in AKT regulation. |
Gain- and loss-of-function studies in kidney tumor cell lines, patient-derived xenograft model, AKT protein stability assays with ZNRF1 |
Oncogene |
Medium |
36966254
|
| 2024 |
ZNRF1 interacts with lipocalin-2 (LCN2), an iron transport-related protein, and this interaction is disrupted by TFAM deficiency or ferroptosis. Overexpression of ZNRF1 maintains mitochondrial integrity and inhibits renal fibrosis. |
Co-immunoprecipitation (ZNRF1-LCN2 interaction), TFAM knockout mice, ferroptosis assays, ZNRF1 overexpression in CKD mouse model |
European journal of pharmacology |
Low |
39349116
|
| 2025 |
ZNRF1-dependent AKT degradation in neurons induces axon initial segment (AIS) shift and increases cell surface localization of voltage-gated sodium channel Nav1.2. ZNRF1 knockout mice exhibit enhanced short-term and contextual fear memory, linking ZNRF1-mediated AKT degradation to AIS plasticity and behavior. |
ZNRF1 knockout mice, AIS morphology analysis, Nav1.2 surface localization (fractionation/imaging), fear conditioning behavioral assays |
Journal of biochemistry |
Medium |
40331626
|
| 2025 |
ZNRF1 in peripheral myeloid cells suppresses MHC class II surface expression on macrophages following EAE induction, thereby limiting antigen-specific T cell proliferation, Th1/Th17 polarization, and neuroinflammation. |
Myeloid-specific ZNRF1 knockout mice, EAE model, flow cytometry for MHC-II surface expression and T cell polarization, CNS immune cell infiltration analysis |
Journal of neuroinflammation |
Medium |
41126242
|
| 2026 |
ZNRF1 E3 ligase activity (requiring catalytically active C184) is required for terminal trafficking and surface exposure of FasL in macrophages. ZNRF1 deficiency weakens the Munc18-2 (Stxbp2)-Syntaxin-3 (Stx3) interaction; reconstitution with wild-type but not catalytically inactive ZNRF1 restores surface FasL, defining a ZNRF1-Munc18-2-Stx3 axis for lysosome-related organelle fusion. |
Myeloid-specific ZNRF1 knockout mice, confocal imaging of LAMP1 and FasL localization, biochemical co-immunoprecipitation (Stxbp2-Stx3 interaction), catalytic mutant (C184A) reconstitution, FasL surface flow cytometry, T cell killing assay |
Cell death & disease |
High |
41896526
|